U.S. markets closed
  • S&P Futures

    4,161.75
    +6.25 (+0.15%)
     
  • Dow Futures

    34,020.00
    +62.00 (+0.18%)
     
  • Nasdaq Futures

    13,920.75
    +23.50 (+0.17%)
     
  • Russell 2000 Futures

    2,229.20
    -0.10 (-0.00%)
     
  • Crude Oil

    63.55
    +0.17 (+0.27%)
     
  • Gold

    1,769.00
    -1.60 (-0.09%)
     
  • Silver

    25.82
    -0.02 (-0.09%)
     
  • EUR/USD

    1.2050
    +0.0009 (+0.07%)
     
  • 10-Yr Bond

    1.6010
    +0.0280 (+1.78%)
     
  • Vix

    17.29
    +1.04 (+6.40%)
     
  • GBP/USD

    1.3988
    +0.0004 (+0.03%)
     
  • USD/JPY

    108.2300
    +0.0800 (+0.07%)
     
  • BTC-USD

    54,832.09
    -1,366.53 (-2.43%)
     
  • CMC Crypto 200

    1,228.30
    -70.66 (-5.44%)
     
  • FTSE 100

    7,000.08
    -19.45 (-0.28%)
     
  • Nikkei 225

    29,169.67
    -515.70 (-1.74%)
     

Amphastar: 1Q Earnings Snapshot

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

RANCHO CUCAMONGA, Calif. (AP) _ Amphastar Pharmaceuticals Inc. (AMPH) on Thursday reported first-quarter net income of $868,000, after reporting a loss in the same period a year earlier.

On a per-share basis, the Rancho Cucamonga, California-based company said it had profit of 2 cents. Earnings, adjusted for non-recurring costs, came to 10 cents per share.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 3 cents per share.

The specialty pharmaceutical company posted revenue of $79.8 million in the period.

Amphastar shares have increased 14% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $22.63, an increase of 16% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMPH at https://www.zacks.com/ap/AMPH